$15.56
+2.35 (+17.79%)
Open$13.71
Previous Close$13.21
Day High$16.44
Day Low$13.70
52W High$2.33
52W Low$0.58
Volume—
Avg Volume109.7K
Market Cap9.61M
P/E Ratio—
EPS$-2.88
SectorPharmaceuticals
Analyst Ratings
Strong Sell
8 analysts
Price Target
+116.3% upside
Current
$15.56
$15.56
Target
$33.65
$33.65
$24.21
$33.65 avg
$46.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.13M | 1.89M | 790.8K |
| Net Income | -5,167,111 | -2,809,060 | 172.0K |
| Profit Margin | -165.1% | -156.9% | 21.8% |
| EBITDA | -4,895,929 | -2,809,503 | 218.3K |
| Free Cash Flow | — | — | 109.5K |
| Rev Growth | +65.6% | +65.6% | +11.4% |
| Debt/Equity | — | — | 0.10 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |